Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Journal of Virology|September 16, 2004
Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoatingRichard J O Barnard, Shakti Narayan, Geethanjali Dornadula, et al.
Journal of Clinical Microbiology|May 6, 2016
Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6Karin S Ku, Ramakrishna K Chodavarapu, Ross Martin, et al.
AIDS (London, England)|June 5, 2002
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DFNicolas A Margot, Erica Isaacson, Ian McGowan, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathwaysMeizhen Feng, Deping Wang, Jay A Grobler, et al.
The Journal of Infectious Diseases|February 21, 2004
Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patientsMichael D Miller, Nicolas Margot, Biao Lu, et al.
Journal of Virology|March 16, 2004
Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tailDonald J Wyma, Jiyang Jiang, Jiong Shi, et al.
Journal of Clinical Microbiology|August 10, 2007
In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populationsYuao Zhu, Maria Curtis, Andrea Snow-Lampart, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarateDamian J McColl, Nicolas A Margot, Michael Wulfsohn, et al.
Pageof 21